HitGen News and Activities

HitGen is a company listed under the stock ticker 688222 (CN).

HitGen has a direct presence in 2 countries.

They are in:

• Biotechnology50%
• Pharmaceuticals50%

View the org chart displaying its 27 main executives

Most searched biographies at HitGen

• Jin Li, Chairman and Chief Executive Officer
• Suibo Li, Director
• Jianguo Li, Director

Create your alert
to follow the executive moves at HitGen.

HitGen has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by HitGen

• Infographic | HitGen FY2024 Q3 Report
• Pharma Peers Unite to Build DNA-Encoded Libraries
• Infographic | HitGen FY2024H1 Report
• Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program
• Infographic | HitGen FY2023&2024Q1 Report
• Vernalis announces a drug discovery collaboration with C4X Discovery in inflammatory disease
• News Press
• HitGen Partners with LabCentral / BioLabs / MBC BioLabs to Accelerate Biotechnology Discovery
• Hox Therapeutics and Vernalis announce a drug discovery collaboration in oncology
• Get ready for the end-of-year sale! Discover the future of drug discovery with OpenDEL™ and save 20% off!
• View more press releases Close

Social media about HitGen

• HitGen on Wikipedia, Google News & Yahoo Finance
• HitGen on LinkedIn, X (Twitter) & YouTube